Ascitis en el paciente cirrótico: ¿cómo abordarla?

Autores:: Yepes Barreto, Ismael
Cadavid Asís, Sergio

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Universidad de Cartagena

Repositorio:: Repositorio Universidad de Cartagena

Idioma:: spa

id	UCART2_c79498424fe2499a29446ba8697be217
oai_identifier_str	oai:repositorio.unicartagena.edu.co:11227/13309
network_acronym_str	UCART2
network_name_str	Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv	Ascitis en el paciente cirrótico: ¿cómo abordarla?
dc.title.translated.eng.fl_str_mv	Ascitis en el paciente cirrótico: ¿cómo abordarla?
title	Ascitis en el paciente cirrótico: ¿cómo abordarla?
spellingShingle	Ascitis en el paciente cirrótico: ¿cómo abordarla? Cirrosis hepática Ascitis Insuficiencia hepática Líquido ascítico.
title_short	Ascitis en el paciente cirrótico: ¿cómo abordarla?
title_full	Ascitis en el paciente cirrótico: ¿cómo abordarla?
title_fullStr	Ascitis en el paciente cirrótico: ¿cómo abordarla?
title_full_unstemmed	Ascitis en el paciente cirrótico: ¿cómo abordarla?
title_sort	Ascitis en el paciente cirrótico: ¿cómo abordarla?
dc.creator.fl_str_mv	Yepes Barreto, Ismael Cadavid Asís, Sergio
dc.contributor.author.spa.fl_str_mv	Yepes Barreto, Ismael Cadavid Asís, Sergio
dc.subject.spa.fl_str_mv	Cirrosis hepática Ascitis Insuficiencia hepática Líquido ascítico.
topic	Cirrosis hepática Ascitis Insuficiencia hepática Líquido ascítico.
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-12-04 00:00:00
dc.date.available.none.fl_str_mv	2020-12-04 00:00:00
dc.date.issued.none.fl_str_mv	2020-12-04
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2215-7840
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/11227/13309
dc.identifier.doi.none.fl_str_mv	10.32997/rcb-2014-3030
dc.identifier.eissn.none.fl_str_mv	2389-7252
dc.identifier.url.none.fl_str_mv	https://doi.org/10.32997/rcb-2014-3030
identifier_str_mv	2215-7840 10.32997/rcb-2014-3030 2389-7252
url	https://hdl.handle.net/11227/13309 https://doi.org/10.32997/rcb-2014-3030
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3030/2562
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2014
dc.relation.citationendpage.none.fl_str_mv	368
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	361
dc.relation.citationvolume.spa.fl_str_mv	5
dc.relation.references.spa.fl_str_mv	Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med.1992;117:215-20. Runyon BA. Care of patients with ascites. N Engl J Med 1994;330:337-42. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146:2259-261. Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91:366-368. Grabau CM, Crago SF, Hoff LK, Simon JA, Melton CA, Ott BJ, Kamath PS. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484-88. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006;44:1039-46. Runyon BA. Management of adult patients with ascites due to cirrhosis: Update 2012. American Association for study of liver disease. 2012. Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990;98:127-33. Dykes PW, Jones JH. Albumin exchange between plasma and ascitic fluid. Clin Sci. 1968;34:185-97. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8:1104-09. Eisenmenger WJ, Ahrens EH, et al. The effect of rigid sodium restriction in patients with cirrhosis of the liver and ascites. J Lab Clin Med. 1949;34:1029-38. Eisenmenger WJ, Blondheim SH, Bongiovanni AM, Kunkel HG. Electrolyte studies on patients with cirrhosis of the liver. J Clin Invest. 1950;29:1491-99. Angeli P, Fasolato S, Mazza E, Okolicsanyi L, Maresio G, Velo E, Galioto A, et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut. 2010;59:98-04. Angeli P, Dalla Pria M, De Bei E, Albino G, Caregaro L, Merkel C, Ceolotto G, et al. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Hepatology. 1994;19:72-9. Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med. 1989;321:1632-38. Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology. 1986;90:1827-33. Sterns RH. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann Intern Med 1987;107:656-64. EASL. clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397-17. Sersté T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, Moreau R, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017-22. Serste T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, Moreau R, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol. 2011;55:794-99. Boyer TD, Zia P, Reynolds TB. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology. 1979;77:215-22. Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diureticresistant ascites. Am J Gastroenterol. 1997;92:394-99. Tito L, Gines P, Arroyo V, Planas R, Panes J, Rimola A, Llach J, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146-51. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164-76. Pérez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology. 1983;84:961-68. Ginés P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987;93:234-41. Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing largevolume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55:1172-81. Choi CH, Ahn SH, Kim DY, Lee SK, Park JY, Chon CY, Moon YM, et al. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study. J Gastroenterol Hepatol. 2005;20:1215-22. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802-10. Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, Nicolini A, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629-35.
dc.rights.spa.fl_str_mv	Revista Ciencias Biomédicas - 2020
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Revista Ciencias Biomédicas - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Cartagena
dc.source.spa.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3030
institution	Universidad de Cartagena
bitstream.url.fl_str_mv	https://repositorio.unicartagena.edu.co/bitstreams/5296500e-cf16-47d4-bfff-b74c5a0e2848/download
bitstream.checksum.fl_str_mv	2bd0f23ee792f0a148d2e7c2de5455d3
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814214207517753344
spelling	Yepes Barreto, IsmaelCadavid Asís, Sergio2020-12-04 00:00:002020-12-04 00:00:002020-12-042215-7840https://hdl.handle.net/11227/1330910.32997/rcb-2014-30302389-7252https://doi.org/10.32997/rcb-2014-3030application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3030/2562Núm. 2 , Año 201436823615Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med.1992;117:215-20.Runyon BA. Care of patients with ascites. N Engl J Med 1994;330:337-42.Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146:2259-261.Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91:366-368.Grabau CM, Crago SF, Hoff LK, Simon JA, Melton CA, Ott BJ, Kamath PS. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484-88.Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006;44:1039-46.Runyon BA. Management of adult patients with ascites due to cirrhosis: Update 2012. American Association for study of liver disease. 2012.Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990;98:127-33.Dykes PW, Jones JH. Albumin exchange between plasma and ascitic fluid. Clin Sci. 1968;34:185-97.Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8:1104-09.Eisenmenger WJ, Ahrens EH, et al. The effect of rigid sodium restriction in patients with cirrhosis of the liver and ascites. J Lab Clin Med. 1949;34:1029-38.Eisenmenger WJ, Blondheim SH, Bongiovanni AM, Kunkel HG. Electrolyte studies on patients with cirrhosis of the liver. J Clin Invest. 1950;29:1491-99.Angeli P, Fasolato S, Mazza E, Okolicsanyi L, Maresio G, Velo E, Galioto A, et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut. 2010;59:98-04.Angeli P, Dalla Pria M, De Bei E, Albino G, Caregaro L, Merkel C, Ceolotto G, et al. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Hepatology. 1994;19:72-9.Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. N Engl J Med. 1989;321:1632-38.Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology. 1986;90:1827-33.Sterns RH. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann Intern Med 1987;107:656-64.EASL. clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397-17.Sersté T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, Moreau R, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017-22.Serste T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, Moreau R, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol. 2011;55:794-99.Boyer TD, Zia P, Reynolds TB. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology. 1979;77:215-22.Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diureticresistant ascites. Am J Gastroenterol. 1997;92:394-99.Tito L, Gines P, Arroyo V, Planas R, Panes J, Rimola A, Llach J, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146-51.Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164-76.Pérez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology. 1983;84:961-68.Ginés P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987;93:234-41.Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing largevolume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55:1172-81.Choi CH, Ahn SH, Kim DY, Lee SK, Park JY, Chon CY, Moon YM, et al. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study. J Gastroenterol Hepatol. 2005;20:1215-22.Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802-10.Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, Nicolini A, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629-35.Revista Ciencias Biomédicas - 2020https://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccesshttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3030Cirrosis hepáticaAscitisInsuficiencia hepáticaLíquido ascítico.Ascitis en el paciente cirrótico: ¿cómo abordarla?Ascitis en el paciente cirrótico: ¿cómo abordarla?Artículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2480https://repositorio.unicartagena.edu.co/bitstreams/5296500e-cf16-47d4-bfff-b74c5a0e2848/download2bd0f23ee792f0a148d2e7c2de5455d3MD5111227/13309oai:repositorio.unicartagena.edu.co:11227/133092024-09-05 15:30:47.804https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Ciencias Biomédicas - 2020metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Ascitis en el paciente cirrótico: ¿cómo abordarla?

Publicaciones similares